Looking for a list of FDA-approved peptides PDF? The FDA doesn't publish one, but here's where approved peptide drugs are listed and what is not approved.
The FDA does not publish a single official PDF called a "list of FDA-approved peptides." Approved peptide drugs are documented one at a time in public FDA databases — Drugs@FDA, the Orange Book, and the Purple Book — and you can search those records by active ingredient, brand name, or approval date. Any "official" peptide PDF circulating online is almost always a reformatted summary of those same public databases.
Does the FDA publish an approved-peptides PDF?
No. The FDA publishes approval letters, prescribing labels, and review documents for individual drug products. It does not maintain a combined roster of peptide drugs in PDF form, and it does not release an annual peptide report.
Searches for a list of fda-approved peptides 2026, or for peptides approved by fda 2026, lead back to the same three sources:
- Drugs@FDA — approval history, labels, and review documents for peptide and small-molecule drugs.
- Orange Book — approved drug products with therapeutic equivalence evaluations.
- Purple Book — licensed biologics, including insulin and other peptide-based proteins.
The FDA does not publish a combined PDF list of FDA-approved peptides; approval records live in Drugs@FDA, the Orange Book, and the Purple Book.
FDA-approved peptide drugs by category
The table below is a starting point, not a legal record. Always confirm current status in Drugs@FDA, because approvals, withdrawals, and label updates happen constantly.
| Category | Example active ingredient (brand) | Representative approved use |
|---|---|---|
| Metabolic / GLP-1 | semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda) | Type 2 diabetes and chronic weight management |
| Reproductive hormones | leuprolide (Lupron), goserelin (Zoladex), cetrorelix (Cetrotide), ganirelix | Prostate cancer, endometriosis, fertility treatment |
| Pituitary / endocrine | octreotide (Sandostatin), lanreotide (Somatuline), desmopressin (DDAVP), oxytocin (Pitocin), tesamorelin (Egrifta) | Acromegaly, neuroendocrine tumors, diabetes insipidus, labor induction, HIV lipodystrophy |
| Bone and calcium | teriparatide (Forteo), abaloparatide (Tymlos), calcitonin | Osteoporosis in selected patients |
| Cardiovascular / hematology | bivalirudin (Angiomax), eptifibatide (Integrilin), angiotensin II (Giapreza) | Anticoagulation during procedures, septic shock |
| Antimicrobial | daptomycin (Cubicin), colistimethate, polymyxin B, bacitracin | Serious bacterial infections and topical infection control |
| Specialty / rare disease | teduglutide (Gattex), pramlintide (Symlin), glatiramer acetate (Copaxone), afamelanotide (Scenesse), setmelanotide (Imcivree), difelikefalin (Korsuva) | Short bowel syndrome, multiple sclerosis, rare metabolic and pigment disorders |
Insulin, somatropin, and similar hormone products are regulated as biologics, so they appear in the Purple Book rather than the Orange Book. That distinction trips up a lot of people building their own PDF.
Peptides that are not FDA-approved
BPC-157, TB-500 (a thymosin beta-4 fragment), ipamorelin, CJC-1295, sermorelin, and GHK-Cu are not FDA-approved for human use in the United States. They are typically sold as "research chemicals" or cosmetic ingredients, which is a category that sidesteps drug approval rather than satisfying it.
If you want to know what peptides are not fda approved, the fastest check is to search the ingredient in Drugs@FDA. If nothing comes back, there is no approval on file.
Most products marketed as peptides for muscle growth fall into that same unapproved category.
How to verify a peptide's approval status
- Open the Drugs@FDA search page and enter the active ingredient name, such as "semaglutide."
- Open each result and read the "Indications and Usage" section of the current label.
- Check the Orange Book for approved products and therapeutic equivalence codes.
- Check the Purple Book instead if the product is a biologic, such as insulin.
- Treat anything sold "for research use only" or "not for human consumption" as unapproved.
A product can be legal to sell as a research chemical and still have zero FDA approval for human use. Those two facts are not in conflict.
Safety, side effects, and sourcing
Even approved peptides have real risks. The prescribing label is where you find documented peptides side effects, which for this drug class commonly include nausea, injection-site reactions, headache, and changes in blood sugar or hormone levels.
Reported peptides for muscle growth side effects include injection-site irritation, fluid retention, and hormonal disruption, but most unapproved products have never been tested in controlled human trials. There is no reliable dosing or purity data to fall back on.
Searches for the best peptides for inflammation mostly return unapproved research chemicals and oral supplements rather than approved drugs. No FDA-approved peptide is labeled for general inflammation, so any product promising that is making a claim the FDA has not reviewed.
Unapproved peptides are often compounded or imported, which means no guaranteed sterility, dose accuracy, or identity testing. Anyone considering an injectable peptide should talk with a licensed healthcare professional first, especially if they take medication for diabetes, cancer, or a bleeding disorder.
Bottom line
The honest answer to a search for a list of FDA-approved peptides pdf is that no single government document exists, but the underlying data is free and searchable. Approved peptides cluster in diabetes and obesity care, hormone therapy, oncology, infectious disease, and a small number of rare diseases.
Everything else — BPC-157, TB-500, ipamorelin, and most "wellness" peptides — sits outside FDA approval. If a vendor claims approval, ask for the NDA or BLA number and verify it in Drugs@FDA before you consider using anything.
Frequently Asked Questions
Is there an official FDA PDF listing all approved peptides?
No. The FDA does not publish a combined PDF of approved peptides. Approval information is spread across Drugs@FDA, the Orange Book, and the Purple Book, and each product has its own approval letter and prescribing label.
Is BPC-157 FDA-approved?
No. BPC-157 is not FDA-approved for human use in the United States, and it is not a lawful dietary supplement ingredient. Products sold as BPC-157 are usually labeled for research use only.
Are any peptides FDA-approved for weight loss?
Yes. Liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are FDA-approved peptide drugs for chronic weight management in eligible patients. They require a prescription and are not sold as over-the-counter supplements.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.